GSK is committed to improve the quality of life by offering people the chance to do more, feel better and live longer. We do this with a responsible global business model focused on sustainable performance and commitment.
For GSK, how we deliver success is just as important as what we achieve. Ensuring our values are embedded in our business is a priority. In September 2018, we announced that we are investing in a new set of commitments across three focus areas, to deliver the greatest possible long-term impact in improving health around the world.
Using our science and technology to address health needs
New medical innovations: Develop differentiated, high-quality and needed medicines, vaccines and consumer healthcare products to improve health.
Global health: Improve global health impact through R&D for infectious diseases that affect children and adolescents in developing countries focusing on HIV, malaria and TB.
Health security: Help the world to better prepare for future disease outbreaks with pandemic potential, and tackle antimicrobial resistance.
Making our products affordable and available
Pricing: Improve the health of millions of people each year by making our products available at responsible prices that are sustainable for our business.
Product reach: Use access strategies to reach 800 million underserved people in developing countries with our products by 2025.
Healthcare access: Partner to improve disease prevention, awareness and access to healthcare services for 12 million people by 2025.
Being a modern employer
Engaged people: Achieve and maintain a competitive employee engagement score by 2022.
Inclusion and diversity: Accelerate our progress on inclusion and diversity, aiming for over 37% female representation in senior roles, and recognition in global LGBT+ indices, by 2022.
Health, wellbeing and development: Be a leading company in how we support employee health, wellbeing and personal development.
How we will report our performance
We will share our progress by reporting against our new commitments each year starting in 2019, for the 2018 year.
More about our approach to responsible business
Health for all
How we are developing innovative products and improving access to healthcare for patients around the world.
BE/COM/0010/15(2) Oct 2017